Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2017

Open Access 01-12-2017 | Research

Convenience without disclosure: a formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania

Authors: Alexis Cooke, Haneefa Saleem, Dorothy Mushi, Jessie Mbwambo, Saria Hassan, Barrot H. Lambdin

Published in: Addiction Science & Clinical Practice | Issue 1/2017

Login to get access

Abstract

Background

Though timely initiation of antiretroviral therapy (ART) is a vital component of effective HIV prevention, care and treatment, people who inject drugs are less likely to receive ART than their non-drug using counterparts. In an effort to increase access to ART for people who inject drugs, we examined perceived benefits, challenges, and recommendations for implementing an integrated methadone and ART service delivery model at an opioid treatment program (OTP) clinic in Dar es Salaam, Tanzania.

Methods

We conducted in-depth interviews with 12 providers and 20 HIV-positive patients at the Muhimbili National Hospital OTP clinic in early 2015. We used thematic content analysis to examine patient and provider perspectives of an integrated model.

Results

Respondents perceived that offering on-site CD4 testing and HIV clinical management at the OTP clinic would improve the timeliness and efficiency of the ART eligibility process, make HIV clinical care more convenient, mitigate stigma and discrimination in HIV care and treatment settings, and improve patient monitoring and ART adherence. However, perceived challenges included overburdened OTP clinic staff and limited space at the clinic to accommodate additional services. Limited privacy at the OTP clinic and its contribution to fear among HIV-positive patients of being stigmatized by their peers at the clinic was a common theme expressed particularly by patients, and often corroborated by providers. Co-dispensing ART and methadone at the clinic’s pharmacy window was viewed as a potential deterrent for patients. Providers felt that an electronic health information system would help them better monitor patients’ progress, but that this system would need to be integrated into existing health information systems. To address these potential barriers to implementing an integrated model, respondents recommended increasing OTP provider and clinic capacity, offering flexible ART dispensing options, ensuring privacy with ART dispensing, and harmonizing any new electronic health information systems with existing systems.

Conclusions

An integrated methadone and ART service delivery model at the MNH OTP clinic could improve access to HIV care and treatment for OTP patients. However, specific implementation strategies must ensure that OTP providers are not overburdened and confidentiality of patients is maintained.
Literature
1.
2.
go back to reference Dutta A, Barker C, Makyao N. Consensus estimates on key population size and HIV prevalence in Tanzania. National AIDS Control Programme (NACP), Ministry of Health and Social Welfare; 2014. Dutta A, Barker C, Makyao N. Consensus estimates on key population size and HIV prevalence in Tanzania. National AIDS Control Programme (NACP), Ministry of Health and Social Welfare; 2014.
3.
go back to reference Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and ICF International 2013. Tanzania HIV/AIDS and Malaria Indicator Survey 2011–12. Dar es Salaam, Tanzania: TACAIDS, ZAC, NBS, OCGS, and ICF International. Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and ICF International 2013. Tanzania HIV/AIDS and Malaria Indicator Survey 2011–12. Dar es Salaam, Tanzania: TACAIDS, ZAC, NBS, OCGS, and ICF International.
4.
go back to reference Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014–28.CrossRefPubMed Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014–28.CrossRefPubMed
5.
go back to reference Gruskin S, Ferguson L, Alfven T, Rugg D, Peersman G. Identifying structural barriers to an effective HIV response: using the National Composite Policy Index data to evaluate the human rights, legal and policy environment. J Int AIDS Soc 2013;16(1):18000. doi:10.7448/IAS.16.1.18000. Gruskin S, Ferguson L, Alfven T, Rugg D, Peersman G. Identifying structural barriers to an effective HIV response: using the National Composite Policy Index data to evaluate the human rights, legal and policy environment. J Int AIDS Soc 2013;16(1):18000. doi:10.​7448/​IAS.​16.​1.​18000.
6.
go back to reference Keeney E, Saucier R. Lowering the threshold: models of accessible methadone and buprenorphine treatment. New York: Open Society Institute; 2010. Keeney E, Saucier R. Lowering the threshold: models of accessible methadone and buprenorphine treatment. New York: Open Society Institute; 2010.
7.
go back to reference Mimiaga MJ, Safren SA, Dvoryak S, Reisner SL, Needle R, Woody G. “We fear the police, and the police fear us”: structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care. 2010;22:1305–13.CrossRefPubMedPubMedCentral Mimiaga MJ, Safren SA, Dvoryak S, Reisner SL, Needle R, Woody G. “We fear the police, and the police fear us”: structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care. 2010;22:1305–13.CrossRefPubMedPubMedCentral
8.
go back to reference Wood E, Kerr T, Tyndall MW, Montaner JS. A review of barriers and facilitators of HIV treatment among injection drug users. AIDS. 2008;22:1247–56.CrossRefPubMed Wood E, Kerr T, Tyndall MW, Montaner JS. A review of barriers and facilitators of HIV treatment among injection drug users. AIDS. 2008;22:1247–56.CrossRefPubMed
9.
go back to reference Krüsi A, Wood E, Montaner J, Kerr T. Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Policy. 2010;21:4–9.CrossRefPubMed Krüsi A, Wood E, Montaner J, Kerr T. Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Policy. 2010;21:4–9.CrossRefPubMed
10.
go back to reference Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376:355–66.CrossRefPubMed Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376:355–66.CrossRefPubMed
11.
go back to reference Rhodes T, Sarang A. Drug treatment and the conditionality of HIV treatment access: a qualitative study in a Russian city. Addiction. 2012;107:1827–36.CrossRefPubMed Rhodes T, Sarang A. Drug treatment and the conditionality of HIV treatment access: a qualitative study in a Russian city. Addiction. 2012;107:1827–36.CrossRefPubMed
12.
go back to reference Lambdin BH, Masao F, Chang O, Kaduri P, Mbwambo J, Magimba A, et al. Methadone treatment for HIV prevention—feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study. Clin Infect Dis. 2014;59:735–42.CrossRefPubMedPubMedCentral Lambdin BH, Masao F, Chang O, Kaduri P, Mbwambo J, Magimba A, et al. Methadone treatment for HIV prevention—feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study. Clin Infect Dis. 2014;59:735–42.CrossRefPubMedPubMedCentral
13.
go back to reference Tran OC, Bruce RD, Masao F, Ubuguyu O, Sabuni N, Mbwambo J, et al. Implementation and operational research: linkage to care among methadone clients living with HIV in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2015;69:e43–8.CrossRefPubMedPubMedCentral Tran OC, Bruce RD, Masao F, Ubuguyu O, Sabuni N, Mbwambo J, et al. Implementation and operational research: linkage to care among methadone clients living with HIV in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2015;69:e43–8.CrossRefPubMedPubMedCentral
14.
go back to reference Gupta A, Mbwambo J, Mteza I, Shenoi S, Lambdin B, Nyandindi C, et al. Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania. Int J Tuberc Lung Dis. 2014;18:793–8.CrossRefPubMedPubMedCentral Gupta A, Mbwambo J, Mteza I, Shenoi S, Lambdin B, Nyandindi C, et al. Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania. Int J Tuberc Lung Dis. 2014;18:793–8.CrossRefPubMedPubMedCentral
17.
go back to reference Milloy M, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203:1215–21.CrossRefPubMedPubMedCentral Milloy M, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203:1215–21.CrossRefPubMedPubMedCentral
18.
go back to reference Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84:188–94.CrossRefPubMed Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84:188–94.CrossRefPubMed
19.
go back to reference Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, et al. A trial of integrated buprenorphine/naloxone and HIV clinical care. Clin Infect Dis. 2006;43(Supplement 4):S184–90.CrossRefPubMed Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, et al. A trial of integrated buprenorphine/naloxone and HIV clinical care. Clin Infect Dis. 2006;43(Supplement 4):S184–90.CrossRefPubMed
21.
go back to reference Green LW, Kreuter MW. Health program planning: an educational and ecological approach. Boston: McGraw-Hill Companies; 2005. Green LW, Kreuter MW. Health program planning: an educational and ecological approach. Boston: McGraw-Hill Companies; 2005.
22.
go back to reference Miles MB, Huberman A, Saldaña J. Qualitative data analysis: a methods sourcebook, Califorinia. Thousand Oaks: SAGE Publications, Inc.; 2014. Miles MB, Huberman A, Saldaña J. Qualitative data analysis: a methods sourcebook, Califorinia. Thousand Oaks: SAGE Publications, Inc.; 2014.
23.
go back to reference Kurth AE, Cleland CM, Des Jarlais DC, Musyoki H, Lizcano JA, Chhun N, et al. HIV prevalence, estimated incidence, and risk behaviors among people who inject drugs in Kenya. J Acquir Immune Defic Syndr. 2015;70:420–7.CrossRefPubMedPubMedCentral Kurth AE, Cleland CM, Des Jarlais DC, Musyoki H, Lizcano JA, Chhun N, et al. HIV prevalence, estimated incidence, and risk behaviors among people who inject drugs in Kenya. J Acquir Immune Defic Syndr. 2015;70:420–7.CrossRefPubMedPubMedCentral
24.
go back to reference Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, et al. Implementing implementation science: an approach for HIV prevention, care and treatment programs. Curr HIV Res. 2015;13:244–6.CrossRefPubMedPubMedCentral Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, et al. Implementing implementation science: an approach for HIV prevention, care and treatment programs. Curr HIV Res. 2015;13:244–6.CrossRefPubMedPubMedCentral
25.
go back to reference Kresina TF, Lubran R. Improving public health through access to and utilization of medication assisted treatment. Int J Environ Res Public Health. 2011;8:4102–17.CrossRefPubMedPubMedCentral Kresina TF, Lubran R. Improving public health through access to and utilization of medication assisted treatment. Int J Environ Res Public Health. 2011;8:4102–17.CrossRefPubMedPubMedCentral
26.
go back to reference Lin C, Li L, Cao X. Client acceptability for integrating antiretroviral therapy in methadone maintenance therapy clinics in Sichuan, China. Subst Use Misuse. 2017;52(1):119–126.CrossRefPubMedPubMedCentral Lin C, Li L, Cao X. Client acceptability for integrating antiretroviral therapy in methadone maintenance therapy clinics in Sichuan, China. Subst Use Misuse. 2017;52(1):119–126.CrossRefPubMedPubMedCentral
27.
go back to reference Bachireddy C, Soule MC, Izenberg JM, Dvoryak S, Dumchev K, Altice FL. Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug Alcohol Depend. 2014;134:106–14.CrossRefPubMed Bachireddy C, Soule MC, Izenberg JM, Dvoryak S, Dumchev K, Altice FL. Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug Alcohol Depend. 2014;134:106–14.CrossRefPubMed
28.
go back to reference Lucas GM, Mullen BA, Weidle PJ, Hader S, McCaul ME, Moore RD. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clin Infect Dis. 2006;42:1628–35.CrossRefPubMed Lucas GM, Mullen BA, Weidle PJ, Hader S, McCaul ME, Moore RD. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clin Infect Dis. 2006;42:1628–35.CrossRefPubMed
29.
go back to reference Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, et al. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam’s injection-driven HIV epidemics. Drug Alcohol Depend. 2012;125:260–6.CrossRefPubMed Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, et al. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam’s injection-driven HIV epidemics. Drug Alcohol Depend. 2012;125:260–6.CrossRefPubMed
30.
go back to reference Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy. 2007;18:262–70.CrossRefPubMed Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy. 2007;18:262–70.CrossRefPubMed
31.
go back to reference Kapadia F, Vlahov D, Wu Y, Cohen MH, Greenblatt RM, Howard AA, et al. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse. 2008;34:161–70.CrossRefPubMed Kapadia F, Vlahov D, Wu Y, Cohen MH, Greenblatt RM, Howard AA, et al. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse. 2008;34:161–70.CrossRefPubMed
32.
go back to reference Cashman SB, Adeky S, Allen AJ III, Corburn J, Israel BA, Montaño J, et al. The power and the promise: working with communities to analyze data, interpret findings, and get to outcomes. Am J Public Health. 2008;98:1407–17.CrossRefPubMedPubMedCentral Cashman SB, Adeky S, Allen AJ III, Corburn J, Israel BA, Montaño J, et al. The power and the promise: working with communities to analyze data, interpret findings, and get to outcomes. Am J Public Health. 2008;98:1407–17.CrossRefPubMedPubMedCentral
33.
go back to reference Edelman EJ, Cole CA, Richardson W, Boshnack N, Jenkins H, Rosenthal MS. Stigma, substance use and sexual risk behaviors among HIV-infected men who have sex with men: a qualitative study. Prev Med Rep. 2016;3:296–302.CrossRefPubMedPubMedCentral Edelman EJ, Cole CA, Richardson W, Boshnack N, Jenkins H, Rosenthal MS. Stigma, substance use and sexual risk behaviors among HIV-infected men who have sex with men: a qualitative study. Prev Med Rep. 2016;3:296–302.CrossRefPubMedPubMedCentral
35.
go back to reference Zamudio-Haas S, Mahenge B, Saleem H, Mbwambo J, Lambdin BH. Generating trust: programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania. Int J Drug Policy. 2016;30:43–51.CrossRefPubMedPubMedCentral Zamudio-Haas S, Mahenge B, Saleem H, Mbwambo J, Lambdin BH. Generating trust: programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania. Int J Drug Policy. 2016;30:43–51.CrossRefPubMedPubMedCentral
36.
go back to reference Lambdin BH, Nyandindi C, Bruce D, Sabuni N, Magimba A, Matiko E. Low threshold services for females who inject drugs: reducing gender inequities in methadone enrolment. J Int AIDS Soc. Int AIDS Society Avenue de France 23, Geneva, 1202, Switzerland; 2015. Lambdin BH, Nyandindi C, Bruce D, Sabuni N, Magimba A, Matiko E. Low threshold services for females who inject drugs: reducing gender inequities in methadone enrolment. J Int AIDS Soc. Int AIDS Society Avenue de France 23, Geneva, 1202, Switzerland; 2015.
37.
go back to reference Lambdin BH, Mbwamb JK, Josiah RM, Bruce RD. Service integration: opportunities to expand access to antiretroviral therapy for people who inject drugs in Tanzania. J Int AIDS Soc 2015;18(1):19936. doi:10.7448/IAS.18.1.19936. Lambdin BH, Mbwamb JK, Josiah RM, Bruce RD. Service integration: opportunities to expand access to antiretroviral therapy for people who inject drugs in Tanzania. J Int AIDS Soc 2015;18(1):19936. doi:10.​7448/​IAS.​18.​1.​19936.
38.
go back to reference Lambdin BH, Bruce RD, Chang O, Nyandindi C, Sabuni N, Zamudio-Haas S, et al. Identifying programmatic gaps: inequities in harm reduction service utilization among male and female drug users in Dar es Salaam, Tanzania. PLoS ONE. 2013;8:e67062.CrossRefPubMedPubMedCentral Lambdin BH, Bruce RD, Chang O, Nyandindi C, Sabuni N, Zamudio-Haas S, et al. Identifying programmatic gaps: inequities in harm reduction service utilization among male and female drug users in Dar es Salaam, Tanzania. PLoS ONE. 2013;8:e67062.CrossRefPubMedPubMedCentral
Metadata
Title
Convenience without disclosure: a formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania
Authors
Alexis Cooke
Haneefa Saleem
Dorothy Mushi
Jessie Mbwambo
Saria Hassan
Barrot H. Lambdin
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Addiction Science & Clinical Practice / Issue 1/2017
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-017-0089-6

Other articles of this Issue 1/2017

Addiction Science & Clinical Practice 1/2017 Go to the issue